Zealand Pharma announces data from the first phase 3-trial with dasiglucagon in Congenital Hyperinsulinism (CHI)

https://www.globenewswire.com/news-release/2020/12/15/2145350/0/en/Zealand-Pharma-announces-data-from-the-first-phase-3-trial-with-dasiglucagon-in-Congenital-Hyperinsulinism-CHI.html

company announcement